Global Drug Device Combination Products Market 2015-2019
- Published: Nov 2015
- Pages: 74
- SKU: IRTNTR7796
The 2021-2025 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!
This market research report by Technavio segments the global drug device combination products market by product (drug eluting stents, prefilled syringes, wearable injectors, and insulin injector drug) and by geography (APAC, EMEA, and the Americas). Key vendors analyzed in this market research are Abbott Laboratories, Becton, Dickinson and Company, Boston Scientific, Medtronic, and Roche Diagnostics.
Market outlook of the global drug device combination products market
Drug device combination products consist of two regulated components, an active pharmaceutical ingredient and a medical device, which are chemically of physically combined to develop a single component. The global drug device combination products market is expected to exhibit rapid growth during the forecast period and is positively affected by factors like its high revenue generating capacity across the healthcare sector and its ability to optimize product life cycles. These factors augment the prospects for growth in this market during the forecast period and results in its impressive CAGR of more than 11% by 2019.
The increase in patient population for chronic diseases is the key driver for the growth of this market. The prevalence of chronic diseases like cardiovascular disease, diabetes, and respiratory diseases is estimated to increase rapidly during the forecast period. This increase in the prevalence of chronic diseases is estimated to bolster the demand for smooth and efficient drug delivery devices, which in turn would augment the prospects for growth in this market during the forecast period.
Product-based segmentation of the drug device combination products market
- Drug-eluting stents
- Prefilled syringes
- Wearable injectors
- Insulin injector drug
In this market research report, Technavio analysts estimate the drug-eluting stents segment to account for more than 36% of the total market share by 2019. The rising prevalence of cardiovascular diseases and the recent rise in demand for minimally invasive surgical procedures are the two major factors that promote growth in this segment during the forecast period.
Geographical segmentation of the drug device combination products market
Technavio’s market research analyst has estimated the Americas to be the major revenue contributing geography during the forecast period. Factors like the rising aging population and the introduction of favorable healthcare reforms aid in promoting the prospects for growth in this region during the forecast period.
Competitive landscape and key vendors
This market is estimated to offer tremendous growth opportunities to the vendors during the forecast period. Vendors that have the ability to efficiently manufacture and offer a wide variety of drug-device combination products, such as infusion pumps, insulin injections, and drug-eluting stents, are expected to gain a competitive edge over their rivals.
Leading vendors in this market are -
- Abbott Laboratories
- Becton, Dickinson and Company
- Boston Scientific
- Roche Diagnostics
Other prominent vendors analyzed in this market study are Aerogen, Airon, Allied Healthcare Products, AstraZeneca, Boehringer Ingelheim, B. Braun Medical, Briggs Healthcare, BIOTRONIK, Cook Medical, Cardinal Health, Consort Medical, Clement Clarke International, Concordia, C.R. Bard, DeVilbiss Healthcare, Ethicon, GlaxoSmithKline, Gerresheimer, Heyer Medical, Invacare, Lepu Medical Technology, MicroPort Scientific, Mylan, Medline Industries, Mallinckrodt, Nypro, Omron Healthcare, PARI Medical, Phillips Healthcare, RPC Bramlage, Salter Labs, Smart inhaler, Stryker, Sunovion Pharmaceuticals, Teleflex, Terumo, Vortran Medical, and W. L. Gore & Associates.
Key questions answered in the report include
- What will the drug device combination products market size and the growth rate be in 2019?
- What are the key factors driving the global drug device combination products market?
- What are the key drug device combination products market trends impacting the market?
- What are the challenges to market growth?
- Who are the key vendors in the global drug device combination products market?
- What are the market opportunities and threats faced by the vendors in the global drug device combination products market?
- Trending factors influencing the market shares of the EMEA, Americas, and APAC?
- What are the key outcomes of the five forces analysis of the global drug device combination products market?
Technavio also offers customization on reports based on specific client requirement.
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Get your FREE sample now!
Get the report (PDF) sent to your email within minutes.
Subscribe & Save
Get lifetime access to our
Did you know?
Did you know?
Did you know?
Want to customize this report?
This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
Technavio's SUBSCRIPTION platform
Register for a free trial today and gain instant access to 17,000+ market research reports.